Senseonics Holdings, Inc. (NYSE:SENS) CEO Purchases $97,650.00 in Stock

Senseonics Holdings, Inc. (NYSE:SENS) CEO Timothy T. Goodnow acquired 315,000 shares of the business’s stock in a transaction on Tuesday, December 10th. The stock was acquired at an average cost of $0.31 per share, for a total transaction of $97,650.00. Following the transaction, the chief executive officer now owns 11,310,355 shares of the company’s stock, valued at approximately $3,506,210.05. The trade was a 2.86 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Senseonics Stock Performance

Shares of NYSE SENS traded up $0.02 during trading on Tuesday, reaching $0.30. 9,343,443 shares of the stock traded hands, compared to its average volume of 3,118,665. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38. The stock has a market capitalization of $181.04 million, a P/E ratio of -2.22 and a beta of 0.77. Senseonics Holdings, Inc. has a 52-week low of $0.25 and a 52-week high of $0.75. The company has a 50-day moving average of $0.32 and a 200-day moving average of $0.38.

Institutional Investors Weigh In On Senseonics

Several institutional investors have recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD boosted its stake in Senseonics by 16.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company’s stock worth $196,000 after purchasing an additional 51,000 shares during the period. Cubist Systematic Strategies LLC increased its position in shares of Senseonics by 25.9% during the second quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock valued at $166,000 after buying an additional 85,501 shares during the period. Vanguard Group Inc. lifted its holdings in shares of Senseonics by 0.7% in the first quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company’s stock worth $11,963,000 after buying an additional 155,715 shares in the last quarter. FMR LLC grew its stake in Senseonics by 48,267.2% during the third quarter. FMR LLC now owns 168,318 shares of the company’s stock valued at $59,000 after acquiring an additional 167,970 shares in the last quarter. Finally, Geode Capital Management LLC increased its holdings in Senseonics by 3.2% during the 3rd quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company’s stock worth $2,042,000 after acquiring an additional 179,103 shares during the period. 12.36% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on SENS shares. StockNews.com assumed coverage on Senseonics in a research note on Tuesday. They set a “sell” rating on the stock. HC Wainwright reissued a “buy” rating and set a $2.00 target price on shares of Senseonics in a research report on Friday, November 15th.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.